Ronald Peck
Keine laufenden Positionen mehr
Vermögen: 439 935 $ am 30.04.2024
Profil
Ronald Peck ist Chief Medical Officer von Arvinas, Inc. In der Vergangenheit war Dr. Peck Vice President für die globale Entwicklung von Yervoy bei Bristol Myers Squibb Co., Chief Medical Officer bei Kolltan Pharmaceuticals, Inc. und Senior Vice President für klinische Forschung bei Tesaro, Inc. sowie Assistenzprofessor an der University of Virginia. Dr. Peck erwarb einen Bachelor-Abschluss an der Georgetown University und einen Doktortitel am Sidney Kimmel Medical College.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
ARVINAS, INC.
0,02% | 31.03.2024 | 13 922 ( 0,02% ) | 439 935 $ | 30.04.2024 |
Ehemalige bekannte Positionen von Ronald Peck
| Unternehmen | Position | Ende |
|---|---|---|
| ARVINAS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 18.03.2024 |
| TESARO INC | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2019 |
Kolltan Pharmaceuticals, Inc.
 Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2016 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01.05.2015 |
| University of Virginia | Corporate Officer/Principal | 01.02.2000 |
Ausbildung von Ronald Peck
| Georgetown University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ARVINAS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Kolltan Pharmaceuticals, Inc.
Kolltan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Kolltan Pharmaceuticals, Inc. engaged in the development of monoclonal antibody drugs. It focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs) for the treatment of cancer and other diseases. The company was founded by Arthur G. Altschul, Jr. and Joseph P. Schlessinger on November 16, 2007 and was headquartered in New Haven, CT. | Health Technology |
